The curriculum is conducted in English and features a 1-year course lenght divided into theorical classes and practical internship at academia, industry, NGO, CROs, amongst others.

As clinical development, public health and regulatory regulations frequently change, our Scientific Board, makes sure that these are constantly updaded in the program, ensuring updated and quality information.

The program culminates with the submission of a thesis and the awarding of a Master’s Diploma from one of the oldest and most respected European universities, the University of Siena.

The internationally recognized Master in Vaccinology and Pharmaceutical Clinical Development has evolved to now include the Drugs study development.

This program demands excellence in every aspect, from the worldwide expertise of the teaching staff to the student’s level of commitment and dedication.

The success of this program is a collaborative effort and a unique partnership between industry and academia to help developing countries to overcome some of the gaps in vaccinology and pharmacology, via a very solid tool: Education. This program helps the countries to build their own resources, to disseminate knowledge, to develop new professionals and especially helps the developing countries to be independent on key aspects such as pharmacovigilance, regulatory and epidemiology.